Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain
- PMID: 1768461
- DOI: 10.1089/aid.1991.7.595
Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain
Abstract
The V3 loop (residues 303-338) of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope protein represents a principal neutralizing determinant for the virus. An HIV-1 proviral clone containing a mutation in the V3 loop was constructed in which the proline residue at position 313 was changed to an alanine (P313-A). This mutation alters the conserved GPGR sequence that is found in the V3 loop sequences of different HIV-1 isolates. The P313-A clone produced virus particles, which were infectious for a number of T-cell lines including MOLT-4, CEM, and SupT1, but demonstrated a relatively low infectivity on the AA5 B-cell line when compared with wild-type viruses, HTLV-IIIB, HXB2/10 (a chimeric molecular clone), and another mutant virus (Q290-T). V3 loop-specific neutralizing polyclonal sera and the 9284 monoclonal antibody, which recognizes the amino side of the V3 loop sequence, effectively blocked infectivity and syncytia formation of all viruses tested. In contrast, the 0.5 beta monoclonal antibody, which is biologically more potent than 9284 and recognizes a different V3 loop determinant, failed to neutralize the P313-A virus. These results suggest that the proline residue in the relatively conserved GPGR "turn" region of the V3 loop is crucial for recognition by the 0.5 beta antibody. The observed variation in sensitivity of the B-cell line to the P313-A virus may reflect the presence of cell-specific factors which could be important in establishing an HIV-1 infection.
Similar articles
-
The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.AIDS Res Hum Retroviruses. 2004 Nov;20(11):1254-8. doi: 10.1089/aid.2004.20.1254. AIDS Res Hum Retroviruses. 2004. PMID: 15588347
-
Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1.AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):735-40. doi: 10.1089/aid.1998.14.735. AIDS Res Hum Retroviruses. 1998. PMID: 9643373
-
Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1067-76. doi: 10.1089/088922201300343753. AIDS Res Hum Retroviruses. 2001. PMID: 11485624
-
The role of the V3 loop of gp120 in HIV infection.AIDS. 1991;5 Suppl 2:S21-33. doi: 10.1097/00002030-199101001-00004. AIDS. 1991. PMID: 1845049 Review. No abstract available.
-
Lack of correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV type 1 isolates.AIDS Res Hum Retroviruses. 1996 Jul 1;12(10):855-8. doi: 10.1089/aid.1996.12.855. AIDS Res Hum Retroviruses. 1996. PMID: 8798969 Review. No abstract available.
Cited by
-
Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.J Virol. 1992 Apr;66(4):1875-83. doi: 10.1128/JVI.66.4.1875-1883.1992. J Virol. 1992. PMID: 1548744 Free PMC article.
-
Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.J Virol. 1992 Apr;66(4):2389-97. doi: 10.1128/JVI.66.4.2389-2397.1992. J Virol. 1992. PMID: 1548769 Free PMC article.
-
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.J Virol. 1993 Oct;67(10):6136-51. doi: 10.1128/JVI.67.10.6136-6151.1993. J Virol. 1993. PMID: 7690418 Free PMC article.
-
Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.J Virol. 1993 Aug;67(8):4557-65. doi: 10.1128/JVI.67.8.4557-4565.1993. J Virol. 1993. PMID: 8331723 Free PMC article.
-
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.J Virol. 1995 Sep;69(9):5723-33. doi: 10.1128/JVI.69.9.5723-5733.1995. J Virol. 1995. PMID: 7543586 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources